Prevalence of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia: Report from a Single Reference Center

References

1. 1.↵
   1. Shovlin CL,
   2. Letarte M

   . Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999;54:714–29 doi:10.1136/thx.54.8.714 pmid:10413726

   FREE Full Text
2. 2.↵
   1. Govani FS,
   2. Shovlin CL

   . Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 2009;17:860–71 doi:10.1038/ejhg.2009.35 pmid:19337313

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Shovlin CL

   . Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 2010;24:203–19 doi:10.1016/j.blre.2010.07.001 pmid:20870325

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Bernabeu C,
   2. Bayrak-Toydemir P,
   3. McDonald J, et al

   . Potential second-hits in hereditary hemorrhagic telangiectasia. J Clin Med 2020;9:3571 doi:10.3390/jcm9113571 pmid:33167572

   CrossRefPubMed
5. 5.↵
   1. McDonald J,
   2. Wooderchak-Donahue W,
   3. VanSant Webb C, et al

   . Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 2015;6:1 doi:10.3389/fgene.2015.00001 pmid:25674101

   CrossRefPubMed
6. 6.↵
   1. Abdalla SA,
   2. Letarte M

   . Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 2006;43:97–110 doi:10.1136/jmg.2005.030833 pmid:15879500

   Abstract/FREE Full Text
7. 7.↵
   1. Faughnan ME,
   2. Mager JJ,
   3. Hetts SW, et al

   . Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med 2020;173:989–1001 doi:10.7326/M20-1443 pmid:32894695

   CrossRefPubMed
8. 8.↵
   1. Serra MM,
   2. Besada CH,
   3. Cabana Cal A, et al

   . Central nervous system manganese induced lesions and clinical consequences in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis 2017;12:92 doi:10.1186/s13023-017-0632-2 pmid:28521822

   CrossRefPubMed
9. 9.↵
   1. Klostranec JM,
   2. Chen L,
   3. Mathur S, et al

   . A theory for polymicrogyria and brain arteriovenous malformations in HHT. Neurology 2019;92:34–42 doi:10.1212/WNL.0000000000006686 pmid:30584075

   CrossRefPubMed
10. 10.↵
    1. Faughnan ME,
    2. Palda VA,
    3. Garcia-Tsao G, et al

    ; HHT Foundation International Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011;48:73–87 doi:10.1136/jmg.2009.069013 pmid:19553198

    Abstract/FREE Full Text
11. 11.↵
    1. Fulbright RK,
    2. Chaloupka JC,
    3. Putman CM, et al

    . MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 1998;19:477–84 pmid:9541302

    PubMedWeb of Science
12. 12.↵
    1. Willemse RB,
    2. Mager JJ,
    3. Westermann CJ, et al

    . Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 2000;92:779–84 doi:10.3171/jns.2000.92.5.0779 pmid:10794291

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Meybodi AT,
    2. Kim H,
    3. Nelson J, et al

    ; Malformation Consortium HHT Investigator Group. Surgical treatment vs nonsurgical treatment for brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a retrospective multicenter consortium study. Neurosurgery 2018;82:253 doi:10.1093/neuros/nyx16 pmid:28973426

    CrossRefPubMed
14. 14.↵
    1. Amenta PS,
    2. Yadla S,
    3. Campbell PG, et al

    . Analysis of nonmodifiable risk factors for intracranial aneurysm rupture in a large, retrospective cohort. Neurosurgery 2012;70:693–701 doi:10.1227/NEU.0b013e3182354d68 pmid:21904261

    CrossRefPubMed
15. 15.↵
    1. Grobelny TJ

    . Brain aneurysms: epidemiology, treatment options, and milestones of endovascular treatment evolution. Dis Mon 2011;57:647–55 doi:10.1016/j.disamonth.2011.08.022 pmid:22036120

    CrossRefPubMed
16. 16.↵
    1. Brown RD Jr.,
    2. Wiebers DO,
    3. Forbes GS

    . Unruptured intracranial aneurysms and arteriovenous malformations: frequency of intracranial hemorrhage and relationship of lesions. J Neurosurg 1990;73:859–63 doi:10.3171/jns.1990.73.6.0859 pmid:2230969

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Rammos SK,
    2. Gardenghi B,
    3. Bortolotti C, et al

    . Aneurysms associated with brain arteriovenous malformations. AJNR Am J Neuroradiol 2016;37:1966–71 doi:10.3174/ajnr.A4869 pmid:27339951

    Abstract/FREE Full Text
18. 18.↵
    1. Vlak MH,
    2. Algra A,
    3. Brandenburg R, et al

    . Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011;10:626–36 doi:10.1016/S1474-4422(11)70109-0 pmid:21641282

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Mohan D,
    2. Munteanu V,
    3. Coman T, et al

    . Genetic factors involves in intracranial aneurysms–actualities. J Med Life 2015;8:336–41 pmid:26351537

    PubMed
20. 20.↵
    1. Kim ST,
    2. Brinjikji W,
    3. Lanzino G, et al

    . Neurovascular manifestations of connective-tissue diseases: a review. Interv Neuroradiol 2016;22:624–37 doi:10.1177/1591019916659262 pmid:27511817

    CrossRefPubMed
21. 21.↵
    1. Maleszewski JJ,
    2. Miller DV,
    3. Lu J, et al

    . Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS). Am J Surg Pathol 2009;33:194–201 doi:10.1097/PAS.0b013e31817f3661 pmid:18852674

    CrossRefPubMed
22. 22.↵
    1. Kim ST,
    2. Brinjikji W,
    3. Kallmes DF

    . Prevalence of intracranial aneurysms in patients with connective tissue diseases: a retrospective study. AJNR Am J Neuroradiol 2016;37:1422–26 doi:10.3174/ajnr.A4718 pmid:26992822

    Abstract/FREE Full Text
23. 23.↵
    1. Vorselaars VM,
    2. Diederik A,
    3. Prabhudesai V, et al

    . SMAD4 gene mutation increases the risk of aortic dilation in patients with hereditary haemorrhagic telangiectasia. Int J Cardiol 2017;245:114–18 doi:10.1016/j.ijcard.2017.06.059 pmid:28874282

    CrossRefPubMed
24. 24.↵
    1. Cavalli G

    . SMAD4 gene mutation and risk of aortic dilation: lessons from hereditary hemorrhagic telangiectasia. Int J Cardiol 2017;245:145–46 doi:10.1016/j.ijcard.2017.07.046 pmid:28874286

    CrossRefPubMed
25. 25.↵
    1. Ishii D,
    2. Takechi A,
    3. Seyama G, et al

    . Ruptured large basilar artery aneurysm associated with an arteriovenous malformation in hereditary hemorrhagic telangiectasia. Neurol Med Chir (Tokyo) 2012;52:502–05 doi:10.2176/nmc.52.502 pmid:22850500

    CrossRefPubMed
26. 26.↵
    1. Chick JF,
    2. Sheehan SE,
    3. Chauhan NR

    . The many faces of hereditary hemorrhagic telangiectasia: median arcuate ligament syndrome, arteriovenous malformations, and cerebral aneurysms. Intern Emerg Med 2012;7:385–86 doi:10.1007/s11739-012-0810-0 pmid:22782335

    CrossRefPubMed
27. 27.↵
    1. Helmchen C,
    2. Nahser HC,
    3. Yousry T, et al

    . Therapy of cerebral aneurysms and arteriovenous vascular malformations in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) (in German). Nervenarzt 1995;66:124–28 pmid:7715751

    PubMed
28. 28.↵
    1. Roy C,
    2. Noseda G,
    3. Arzimanoglou A, et al

    . Rendu Osler disease revealed by ruptured cerebral arterial aneurysm in an infant. Arch Fr Pediatr 1990;47:741–42 pmid:2082850

    PubMedWeb of Science
29. 29.↵
    1. Sobel D,
    2. Norman D

    . CNS manifestations of hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 1984;5:569–73 pmid:6435422

    Abstract/FREE Full Text
30. 30.↵
    1. Fisher M,
    2. Zito JL

    . Focal cerebral ischemia distal to a cerebral aneurysm in hereditary hemorrhagic telangiectasia. Stroke 1983;14:419–21 doi:10.1161/01.str.14.3.419 pmid:6658911

    Abstract/FREE Full Text
31. 31.↵
    1. Kamiyama K,
    2. Okada H,
    3. Niizuma H, et al

    . A case report: Osler-Weber-Rendu disease with cerebral aneurysm, cerebral arteriovenous malformation and pulmonary arteriovenous fistula (author’s transl). No Shinkei Geka 1981;9:67–72 pmid:7231629

    PubMed
32. 32.↵
    1. Román G,
    2. Fisher M,
    3. Perl DP, et al

    . Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol 1978;4:130–44 doi:10.1002/ana.410040207 pmid:707984

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Grollmus J,
    2. Hoff J

    . Multiple aneurysms associated with Osler-Weber-Rendu disease. Surg Neurol 1973;1:91–93 pmid:4772800

    PubMed
34. 34.↵
    1. Brown RD Jr.,
    2. Huston J,
    3. Hornung R, et al

    . Screening for brain aneurysm in the Familial Intracranial Aneurysm study: frequency and predictors of lesion detection. J Neurosurg 2008;108:1132–38 doi:10.3171/JNS/2008/108/6/1132 pmid:18518716

    CrossRefPubMed
35. 35.↵
    1. Caranci F,
    2. Briganti F,
    3. Cirillo L, et al

    . Epidemiology and genetics of intracranial aneurysms. Eur J Radiol 2013;82:1598–605 doi:10.1016/j.ejrad.2012.12.026 pmid:23399038

    CrossRefPubMed
36. 36.↵
    1. Maher CO,
    2. Piepgras DG,
    3. Brown RD Jr., et al

    . Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001;32:877–82 doi:10.1161/01.str.32.4.877 pmid:11283386

    Abstract/FREE Full Text
37. 37.↵
    1. Krings T,
    2. Ozanne A,
    3. Chng SM, et al

    . Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age: review of 50 consecutive patients aged 1 day-60 years. Neuroradiology 2005;47:711–20 doi:10.1007/s00234-005-1390-8 pmid:16136265

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Brinjikji W,
    2. Iyer VN,
    3. Yamaki V, et al

    . Neurovascular manifestations of hereditary hemorrhagic telangiectasia: a consecutive series of 376 patients during 15 years. AJNR Am J Neuroradiol 2016;37:1479–86 doi:10.3174/ajnr.A4762 pmid:27012295

    Abstract/FREE Full Text
39. 39.↵
    1. Woodall MN,
    2. McGettigan M,
    3. Figueroa R, et al

    . Cerebral vascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 2014;120:87–92 doi:10.3171/2013.10.JNS122402 pmid:24236651

    CrossRefPubMed
40. 40.↵
    1. Ring NY,
    2. Latif MA,
    3. Hafezi-Nejad N, et al

    . Prevalence of and factors associated with arterial aneurysms in patients with hereditary hemorrhagic telangiectasia: 17-year retrospective series of 418 patients. J Vasc Interv Radiol 2021;32:1661–69 doi:10.1016/j.jvir.2021.08.018 pmid:34478850

    CrossRefPubMed
41. 41.↵
    1. Brinjikji W,
    2. Iyer VN,
    3. Wood CP, et al

    . Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis. J Neurosurg 2017;127:302–10 doi:10.3171/2016.7.JNS16847 pmid:27767404

    CrossRefPubMed
42. 42.↵
    1. Cagnazzo F,
    2. Brinjikji W,
    3. Lanzino G

    . Arterial aneurysms associated with arteriovenous malformations of the brain: classification, incidence, risk of hemorrhage, and treatment-a systematic review. Acta Neurochir (Wien) 2016;158:2095–104 doi:10.1007/s00701-016-2957-3 pmid:27644700

    CrossRefPubMed
43. 43.↵
    1. Chalouhi N,
    2. Hoh BL,
    3. Hasan D

    . Review of cerebral aneurysm formation, growth, and rupture. Stroke 2013;44:3613–22 doi:10.1161/STROKEAHA.113.002390 pmid:24130141

    FREE Full Text
44. 44.↵
    1. Dingenouts CK,
    2. Goumans M-J,
    3. Bakker W

    . Mononuclear cells and vascular repair in HHT. Front Genet 2015;6:114 doi:10.3389/fgene.2015.00114 pmid:25852751

    CrossRefPubMed
45. 45.↵
    1. Aristorena M,
    2. Gallardo-Vara E,
    3. Vicen M, et al

    . MMP-12, secreted by pro-inflammatory macrophages, targets endoglin in human macrophages and endothelial cells. Int J Mol Sci 2019;20:3107 doi:10.3390/ijms20123107 pmid:31242676

    CrossRefPubMed
46. 46.↵
    1. Lebrin F,
    2. Srun S,
    3. Raymond K, et al

    . Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 2010;16:420–48 doi:10.1038/nm.2131 pmid:20364125

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Wu V,
    2. Lee JM,
    3. Vozoris NT, et al

    . Weekly epistaxis duration as an indicator of epistaxis severity in hereditary hemorrhagic telangiectasia: preliminary results from a randomized controlled trial. Laryngoscope Investig Otolaryngol 2021;6:370–75 doi:10.1002/lio2.561 pmid:34195356

    CrossRefPubMed
48. 48.↵
    1. Greving JP,
    2. Wermer MJH,
    3. Brown RD Jr., et al

    . Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol 2014;13:59–66 doi:10.1016/S1474-4422(13)70263-1 pmid:24290159

    CrossRefPubMed